Kyvor

Chennai, India Founded: 2016 • Age: 10 yrs Minicorn
Precision cancer diagnostics are delivered via genomic profiling analysis.

About Kyvor

Kyvor is a Healthcare company based in Chennai (India) founded in 2016 by Abilesh Malli Gunasekar. Precision cancer diagnostics are delivered via genomic profiling analysis. Kyvor has raised $159.84 thousand across 1 funding round from investors including Anji Jain. Kyvor was last valued at $1.61 million in July 2017. Its chief executive, as recorded, is Abilesh Malli Gunasekar. Its Indian entity Kyvor Genomics Private Limited reported revenue of β‚Ή50.7 Lakh. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Pan Cancer.

Company details

Kyvor was founded in 2016 in Chennai, India, as a genomics startup focused on precision oncology. Targeted therapy recommendations are offered based on patient genotypes through the CANLYTx product, which performs comprehensive genomic profiling for solid tumors using next-generation sequencing. Operations center on diagnostic services in the healthcare sector, supporting clinical decisions for cancer treatment.

Key Metrics
  • Annual Revenue
    ₹50.7 Lakh

    FY 2024 · +15% YoY

  • Net Loss
    -₹37.3 Lakh

    FY 2024 · -74% margin

  • EBITDA
    -₹17.1 Lakh

    FY 2024 · -34% margin

  • Total Equity Funding
    $159.84K (USD)

    in 1 rounds

  • Latest Funding Round
    $159.84K (USD), Angel Round

    Jul 2017

Funding Insights of Kyvor

Kyvor has successfully raised a total of $159.84K through 1 strategic funding round. The most recent funding activity was a Angel Round of $159.84 thousand completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $159,840
  • Total Rounds 1
  • Last Round Angel Round β€” $159,840
  • First Round $159,840

    (Jul 2017)

  • Investors Count 1

All 1 funding rounds of Kyvor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2017$159,840Angel Round$1.61MAnji Jain
–
Valuation history
DateValuationStage
Jul 2017$1.61Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.61M (Jul 2017). 1 investors in total: 0 institutional and 1 angel.

Investors in Kyvor

Kyvor has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Anji Jain.

All
Angel
InvestorDescriptionFounded YearDomainLocation

Anji Jain

unknown_318e457175cc42aba
Premium access

Investor details for Kyvor

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Kyvor Genomics Private Limited (Kyvor)

Kyvor Genomics Private Limited is the primary company behind Kyvor. The board of Kyvor Genomics Private Limited currently have 3 directors; the longest-serving is Abilesh Gunasekar Malli, appointed in 2013. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Abilesh Gunasekar Malli
DIN 02600271
Director16 Aug 201313 yrs 2 moKyvor Genomics Private Limited
Jayanthi Gunasekar Malli
DIN 02600307
Director16 Aug 201313 yrs 2 moKyvor Genomics Private Limited
Dimple Jain
DIN 07108336
Additional Director22 Oct 20188 yrsKyvor Genomics Private Limited

People of Kyvor

1 people are tracked at Kyvor (1 in leadership).

NameRoleGroup
Founder & CEOLeadership
Premium access

Complete people profiles for Kyvor

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Kyvor

Figures of Kyvor Genomics Private Limited, the primary company behind Kyvor, for FY 2024. Revenue was ₹50.7 Lakh (+15% year on year). Net loss was -₹37.3 Lakh (-74% margin). EBITDA was -₹17.1 Lakh (-34% margin). Revenue has grown at a compounded annual rate of -6% over three years and +15% over five years.

  • ₹50.7 LakhRevenue · FY 2024 · +15% YoY
  • -₹37.3 LakhNet loss · -74% margin
  • -₹17.1 LakhEBITDA · -34% margin
  • ₹11.1 LakhPaid-up capital
  • -6%Revenue CAGR, 3 years
  • +15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Kyvor Genomics Private Limited are on its company page.

Premium access

Detailed financial statements for Kyvor

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Kyvor

3 dated milestones of Kyvor across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Kyvor is founded.
  2. Funding First funding round of $160K.
  3. Milestone Reaches Minicorn status.

Web traffic of Kyvor

The website of Kyvor (kyvorgenomics.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 65.8% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Kyvor

Kyvor was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Kyvor is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Abilesh Malli Gunasekar is the CEO of Kyvor, as recorded in our data. They have also founded this company.

Kyvor is a funded company, having raised a total of $159.84K across 1 funding round to date. The company's 1st funding round was a Angel Round of $159.84K, raised on Jul 2017.

The primary company behind Kyvor, Kyvor Genomics Private Limited, reported revenue of β‚Ή50.7 Lakh for FY 2024, up 15% year on year.

Kyvor was founded in 2016 in Chennai, India, as a genomics startup focused on precision oncology. Targeted therapy recommendations are offered based on patient genotypes through the CANLYTx product, which performs comprehensive genomic profiling for solid tumors using next-generation sequencing. Operations center on diagnostic services in the healthcare sector, supporting clinical decisions for cancer treatment.

Kyvor has 1 investor. Key investors include Anji Jain.

The valuation of Kyvor is $1.61M as of Jul 2017.

Kyvor operates through Kyvor Genomics Private Limited.

The legal entities of Kyvor currently have 3 directors, including Abilesh Gunasekar Malli, Jayanthi Gunasekar Malli, Dimple Jain.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available